Winan van Houdt, Surgical Oncologist at Antoni van Leeuwenhoek and Program Coordinator for Rare Cancers at the Netherlands Cancer Institute, shared a post on LinkedIn:
“Throwback to PhD Viva April 11 – examining Prof Marc Moncrieff together with Thomas Carter at the University of East Anglia. We had no choice but to let him pass without corrections since he is one of the worlds experts of sentinel lymph node biopsy in melanoma and also PI of the Melmart trial. Congrats Marc!”
More posts featuring Winan van Houdt.
